REVIEW
|
doi:10.20944/preprints202007.0061.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
COVID-19; SARS-CoV-2; Coronavirus; Substance Use Disorder (SUD); Immunology; Neuroinflammation; Blood-Brain Barrier (BBB); hypothalamic–pituitary–adrenal (HPA) axis
Online: 5 July 2020 (10:21:47 CEST)